TP53 and familial pancreatic carcinoma: More importantly, nonsense and frameshift/splice-site mutations were solely evident in patients with a short OS and DFS, corroborating previously published results linking pathogenic mutations of TP53 to a shortened disease-free survival of pancreatic cancer [44].